GlassScriptPhysician profile
Jacquelyn Gonzales
NPI 1629372149
$1,578.32
in general payments reported to CMS, 2019-2025
10 companies · $278 in 2025
The $278 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $309 · 2022: $274 · 2023: $275 · 2024: $443 · 2025: $278.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $996.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $995.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $425.64 | 2023-2024 | Darzalex, Tecvayli, Carvykti |
| Abbvie INC. | $413.57 | 2022-2025 | |
| Incyte Corporation | $262.97 | 2021 | |
| Daiichi Sankyo INC. | $144.50 | 2025 | Enhertu |
| Astrazeneca Pharmaceuticals LP | $124.99 | 2023 | Imfinzi |
| Pharmacyclics LLC, An Abbvie Company | $73.58 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $40.00 | 2024 | Libtayo |
| Genzyme Corporation | $35.94 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $31.29 | 2025 | Opdualag |
| Jazz Pharmaceuticals INC. | $25.84 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacquelyn Gonzales listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.